G01N 2333/78
Connective tissue peptides
Official title: Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
G01N2333/78 (Connective tissue peptides) appears on 370 US grants and 588 published applications in this corpus.
Search patents in G01N- Granted patents
- 370
- Published applications
- 588
- Assignees
- 360
- Inventors
- 1,247
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 4 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 3 | 0 |
| 1991 | 0 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 4 | 0 |
| 1995 | 3 | 0 |
| 1996 | 2 | 0 |
| 1997 | 10 | 0 |
| 1998 | 6 | 0 |
| 1999 | 15 | 0 |
| 2000 | 22 | 0 |
| 2001 | 4 | 1 |
| 2002 | 6 | 15 |
| 2003 | 8 | 22 |
| 2004 | 10 | 10 |
| 2005 | 8 | 21 |
| 2006 | 12 | 23 |
| 2007 | 5 | 13 |
| 2008 | 5 | 10 |
| 2009 | 4 | 16 |
| 2010 | 12 | 16 |
| 2011 | 11 | 17 |
| 2012 | 15 | 27 |
| 2013 | 8 | 24 |
| 2014 | 14 | 20 |
| 2015 | 16 | 36 |
| 2016 | 17 | 40 |
| 2017 | 17 | 29 |
| 2018 | 18 | 33 |
| 2019 | 16 | 25 |
| 2020 | 19 | 29 |
| 2021 | 17 | 23 |
| 2022 | 13 | 30 |
| 2023 | 9 | 30 |
| 2024 | 9 | 26 |
| 2025 | 13 | 27 |
| 2026 | 7 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for measuring COPD biomarkers25 Aug 2026US 12,716,898 B2St. John's University
- Method for manufacturing microchip for blood coagulation test11 Aug 2026US 12,702,981 B2ZACROS Corporation
- Automated immunoanalyzer system for performing diagnostic assays for autoimmune and infectious diseases28 Jul 2026US 12,693,221 B2Hycor Biomedical, Inc.
- Biomarkers of early osteoarthritis16 Jun 2026US 12,656,343 B2CD Diagnostics, Inc.
- Serum albumin-binding fibronectin type III domains14 Apr 2026US 12,599,652 B2Janssen Biotech, Inc.
- Selective glucocorticoid receptor modifiers for treating impaired skin wound healing1 Oct 2026US 2026/0294918 A1Akribes Biomedical GmbH
- Prophylactic or therapeutic against exacerbation or recurrence of cancer, and screening method therefor17 Sep 2026US 2026/0276624 A1
- Diagnosis, monitoring or prognosis of type 2 diabetes, impaired glucose tolerance or prediabetes17 Sep 2026US 2026/0276653 A1FundacióN PúBlica Galega Instituto De InvestigacióN Sanitaria De Santiago De Compostela
- Fibroblast Activation Markers and TGFBI in Therapy3 Sep 2026US 2026/0258118 A1KeyBioscience AG
- Collagen Type VI Alpha-6 Assay3 Sep 2026US 2026/0259223 A1Nordic Bioscience A/S
Most cited
By later US patents
- Polybifunctional reagent having a polymeric backbone and photoreactive moieties and bioactive groups478US 6,121,027 ASurModics, Inc. · 2000
- Point of care diagnostic systems236US 6,394,952 B1Adeza Biomedical Corporation · 2002
- Artificial antibody polypeptides170US 6,703,199 B1Research Corporation Technologies, Inc. · 2004
- Point of care diagnostic systems165US 6,867,051 B1Adeza Biomedical Corporation · 2005
- Artificial antibody polypeptides158US 6,673,901 B2Research Corporation Technologies, Inc. · 2004